,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #ffgj  ,,in ,,the ,,house ,,of  
,,representatives  ,may #a1 #bjbj,ms4   
,eshoo 7for herself and ,mrs4 ,brooks of
 ,indiana7 introduced the following     
bill2 which was referred to the         
,committee on ,energy and ,commerce  ,a 
,,bill  ,to provide for an exploration  
of strategies to increase domestic      
manufacturing and diversify the supply  
chain of critical drugs1 and for other  
purposes4  #a4 ,short title ,this ,act  
may be cited as the ,prescription for   
,american ,drug ,independence ,act of   
#bjbj4  #b4 ,national ,academies        
strategies ,to increase domestic        
manufacturing of critical drugs  7a7 ,in
 general ,not later than #ad days after 
the date of enactment of this ,act1 the 
,secretary of ,health and ,human        
,services shall enter into an agreement 
with the ,national ,academies of        
,sciences1 ,engineering1 and ,medicine  
7referred to in this section as the     
,national ,academies7 under which1 not  

later than #ij days after the date of   
entering into the agreement1 the        
,national ,academies will-- 7#a7        
establish a committee of experts who are
 knowledgeable about drug supply issues1
 including-- 7,a7 sourcing and          
production of critical drugs2  7,b7     
sourcing and production of active       
pharmaceutical ingredients in critical  
drugs2  7,c7 the raw materials and other
 components for critical drugs2 and     
7,d7 the public health and national     
security implications of the current    
supply chain for critical drugs2  7#b7  
convene a public symposium to-- 7,a7    
analyze the impact of ,united ,states   
dependence on the foreign manufacturing 
of critical drugs on patient access and 
care1 including in hospitals and        
intensive care units2 and  7,b7         
recommend strategies to end ,united     
,states dependence on foreign           
manufacturing to ensure the ,united     
,states has a diverse and vital supply  
chain for critical drugs to protect the 

,nation from natural or hostile         
occurrences2 and  7#c7 submit a report  
on the symposium's proceedings to the   
,congress and publish a summary of such 
proceedings on the public website of the
 ,national ,academies4  7b7 ,symposium  
,in carrying out the agreement under    
subsection 7a71 the ,national ,academies
 shall consult with-- 7#a7 the          
,department of ,health and ,human       
,services1 the ,department of ,homeland 
,security1 the ,department of ,defense1 
the ,department of ,commerce1 the       
,department of ,state1 the ,department  
of ,veterans ,affairs1 the ,department  
of ,justice1 and any other ,federal     
agencies as appropriate2 and  7#b7      
relevant stakeholders1 including drug   
manufacturers1 health care providers1   
medical professional societies1         
,state-based societies1 public health   
experts1 ,state and local public health 
departments1 ,state medical boards1     
patient groups1 health care             
distributors1 wholesalers and group     

purchasing organizations1 pharmacists1  
and other entities with experience in   
health care and public health1 as       
appropriate4  7c7 ,definitions ,for the 
purposes of this section3 7#a7 ,the term
 critical drug means a drug that is     
described in subsection 7a7 of section  
#ejf;,c of the ,federal ,food1 ,drug1   
and ,cosmetic ,act 7#ba ,u4,s4,c4       
#cef;c7 7relating to notification of any
 discontinuance or interruption in the  
production of life-saving drugs74  7#b7 
,the term drug has the meaning given to 
such term in section #bja of the        
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cba74